Wembrace Biopharma

Wembrace Biopharma, headquartered in Delhi, India, is an active Indian pharmaceutical manufacturer specializing in the development and manufacture of high-quality, affordable chemotherapeutic formulations for cancer care. With over thirty years of experience, it offers more than fifty anti-cancer medicines as well as nutraceuticals. The company operates WHO GMP-certified manufacturing facilities in Himachal Pradesh and Punjab, and serves both domestic and international markets. Its large portfolio primarily consists of commercialized generic or branded generic oncology drugs, and it does not appear to develop novel new chemical entities or biologics. Clinical trial results are not publicly disclosed, as its products are marketed generics rather than novel clinical-stage assets. There are no public listings or major acquisitions associated with the firm. Its main therapeutic area is cancer/oncology across multiple tumor types using standard-of-care agents.